SCHEMBL5654170

SCHEMBL5654170

Cc1ccccc1CN(C(=O)c1ccc(-c2ccccc2)cc1)[C@@H](CCC(=O)O)C(N)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.41
PPARD Q03181 4/20 0.40
ALDH1A1 P00352 3/20 0.39
HPGD P15428 3/20 0.39
MAPT P10636 1/20 0.39
LMNA P02545 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
FFAR1 O14842 1/20 0.38
CYP1A2 P05177 1/20 0.38
RAB9A P51151 1/20 0.38
HIF1A Q16665 1/20 0.38
ADAMTS4 O75173 1/20 0.36
ADAMTS5 Q9UNA0 1/20 0.36
TAS2R14 Q9NYV8 1/20 0.35
MMP2 P08253 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35
GAA P10253 1/20 0.35
TRPM8 Q7Z2W7 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4369489 0.84 PTGES (0.45) MMP12ALDH1A1HPGDMAPTLMNA
SCHEMBL4369493 0.81 EPHX1 (0.41) MMP12HPGDLMNASMN1; SMN2FFAR1
SCHEMBL2246642 0.81 MMP12 (0.41) MMP12ALDH1A1HPGDMAPTLMNA
SCHEMBL5651081 0.80 PTGES (0.53) MMP12ADAMTS4ADAMTS5MMP2MMP8
SCHEMBL4358333 0.79 PPARD (0.42) MMP12PPARDALDH1A1HPGDMAPT
SCHEMBL4365889 0.79 PTGES (0.45) MMP12RAB9AADAMTS4ADAMTS5MMP2
SCHEMBL2247308 0.79 TRPM8 (0.43) MMP12ALDH1A1HPGDMAPTLMNA
SCHEMBL4357426 0.79 MMP12 (0.43) MMP12ALDH1A1HPGDMAPTLMNA
SCHEMBL2246723 0.78 MMP12 (0.44) MMP12MMP2MMP8MMP13TRPM8
SCHEMBL5653525 0.78 SRD5A2 (0.44) MMP12FFAR1MMP13MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043066-A1 Glutamate aggrecanase inhibitors WYETH (US) 2007-02-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043066-A1 Glutamate aggrecanase inhibitors ADAMTS5, ADAMTS1, ADAMTS7 MMP12 54/4885PPARD 3286/4885ALDH1A1 991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.